Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Mukul Sharma(Population Health Research Institute), Graeme J. Hankey, Scott E. Kasner(University of Pennsylvania), Laetitia Yperzeele(University of Antwerp), Else Charlotte Sandset, Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Georgios Tsivgoulis(National and Kapodistrian University of Athens), David Gailani(Vanderbilt University Medical Center), Pierre Amarenco(Assistance Publique – Hôpitaux de Paris), David Tanné, Daniel Strbian(Helsinki University Hospital), Gisele Sampaio Silva(Universidade Federal de São Paulo), Shrikant I. Bangdiwala(Population Health Research Institute), Carlos A. Molina(MSD (Mexico)), Ashfaq Shuaib(University of Alberta), Anja Kahl(Bristol-Myers Squibb (United States)), Helmi L. Lutsep(Oregon Health & Science University), Nana Goar Pogosova(National Medical Research Center of Cardiology), Antonio Araúz(Instituto Nacional de Neurología y Neurocirugía), Jens Eckstein, Danshi Li(Montreal Heart Institute), Jesse Dawson(University of Glasgow), Danilo Toni(Sapienza University of Rome), Chahin Pachaï(Bristol-Myers Squibb (United States)), Anna Członkowska(Institute of Psychiatry and Neurology), Dániel Bereczki(Semmelweis University), Grigor Abelian(Bristol-Myers Squibb (United States)), George Ntaios(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Mark Donovan(Bristol-Myers Squibb (United States)), Álvaro Avezum(Sociedade de Nefrologia do Estado de São Paulo), Turgut Tatlisumak(University of Gothenburg), Charlotte Cordonnier, Joerg R. Weber(Humboldt-Universität zu Berlin), Richard A. Bernstein(Northwestern University), Hans‐Christoph Diener(Essen University Hospital), Pablo M Lavados(Universidad del Desarrollo), Sebastián F. Ameriso(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Matthias Endres(German Center for Neurodegenerative Diseases), Paul von Weitzel‐Mudersbach(Regionshospitalet Herning), Byung‐Woo Yoon(China Medical University)
Cited by 95
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k